Back to Journals » OncoTargets and Therapy » Volume 7

Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity

Total article views   HTML views PDF downloads Totals
8,489 Dovepress* 7,604+ 1,319 8,923
PubMed Central* 885 312 1,197
Totals 8,489 1,631 10,120
*Since 21 March 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar